Interaction(s) between nutrients, essential fatty acids, eicosanoids, free radicals, nitric oxide, anti-oxidants and endothelium and their relationship to human essential hypertension

Medical Science Research

Volumn 28, Issue 2, 2000, Pages 75-83

  Das, U N ^a  

^a EFA Sciences LLC   (United States)

Author keywords

Anti oxidants; Eicosanoids; Endothelium; Essential fatty acids; Essential hypertension; Free radicals; Insulin resistance; Nitric oxide; Nutrients; Syndrome X

Indexed keywords

ACYL COENZYME A DESATURASE; ALPHA TOCOPHEROL; ANTIOXIDANT; ARACHIDONIC ACID; ASCORBIC ACID; CALCIUM; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; FREE RADICAL; GAMMA LINOLENIC ACID; ICOSANOID; ICOSAPENTAENOIC ACID; INSULIN; LINOLENIC ACID; MAGNESIUM; NICOTINIC ACID; NITRIC OXIDE; POTASSIUM; PROSTACYCLIN; PROSTAGLANDIN E1; PYRIDOXINE; RETINOL; SELENIUM; SODIUM; SUPEROXIDE; UNINDEXED DRUG; VASODILATOR AGENT; ZINC;

ANTIOXIDANT ACTIVITY; ARTICLE; ASIAN; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CALCIUM INTAKE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ELECTROLYTE INTAKE; ENDOTHELIUM LESION; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FAT INTAKE; FATTY ACID METABOLISM; HUMAN; HYPERLIPIDEMIA; ICOSANOID METABOLISM; INCIDENCE; INSULIN RESISTANCE; LIPID BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL VALUE; PATHOGENESIS; POTASSIUM INTAKE; PROSTAGLANDIN SYNTHESIS; RISK ASSESSMENT; RISK FACTOR; SODIUM INTAKE; SOUTHEAST ASIA; SYNDROME X; VASCULAR ENDOTHELIUM; VASODILATATION;

OXY;

EID: 0033765863     PISSN: 02698951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. McCarron DA, Morris CD, Henry HJ, Stanton JL. Blood pressure and nutrient intake in the United States. Science 1984; 224:1392-1398.
2. Das UN. Minerals, trace elements, and vitamins interact with essential fatty acids and prostaglandins to prevent hypertension, thrombosis, hypercholesterolaemia and atherosclerosis and their attendant complications. IRCS Med Sci 1985; 13:684-687.
3. Tannen RL. Effects of potassium on blood pressure control. Ann Intern Med 1983; 98:773-780.
4. Department of Health and Human Services, DHSS Publications. (PH.5) London, UK; 1983. pp. 83-1676.
5. Kolata G. Does a lack of calcium cause hypertension? Science 1984; 225:705-706.
6. Altura BM, Altura BT, Carella A. Magnesium deficiency-induced spasms of umbilical vessels: relation to pre-eclampsia, hypertension, growth retardation. Science 1983; 221:376-378.
7. Siegel G, Walter A, Gustavsson H, Lindman B. Magnesium and membrane function in vascular smooth muscle. Artery 1981; 9:232-252.
8. Das UN. Nutrients, essential fatty acids and prostaglandins interact to augment immune responses and prevent genetic damage and cancer. Nutrition 1989; 5:106-110.
9. Das UN. Essential fatty acids; Biology and their clinical implications. Asia Pacif J Pharmacol 1991; 6:317-330.
10. Das UN, Horrobin DF, Begin ME, Huang YS, Cunnane SC, Manku MS, etal. Clinical significance of essential fatty acids. Nutrition 1988; 4:337-341.
11. Tobian L, Ganguli M, Johnson MA, Iwai J. Influence of renal prostaglandins and dietary linoleate on hypertension in Dahl rats. Hypertension 1982; 4(supp): 149-153.
12. Huffman P, Forster W, Markov Ch M. Attenuation of blood pressure increase in spontaneously hypertensive rats by diets enriched with polyunsaturated fatty acids. Prostaglandins Leukotrienes Med 1982; 8:151-156.
13. lacono JM, Judd JT, Marshall MW, Canary JJ, Dougherty RM, Macklin JF et al. The role of dietary essential fatty acids and prostaglandins in reducing blood pressure. Prog Lipid Res 1981; 20:349-364.
14. Hassall CH, Kirtland SJ. Dihomo-gamma-linolenic acid reverses hypertension induced in rats by diets rich in saturated fat. Lipids 1984; 19:699-703.
15. Mills DE, Ward R. Attenuation of psychosocial stress-induced hypertension by gamma-linolenic acid (GLA) administration in rats. Proc Soc Exp Biol Med 1984; 176:32-37.
16. Woodcock BE, Smith E, Lambert WH, Jones WM, Galoway JH, Greaves M et al. Beneficial effect of fish oil on blood viscosity in peripheral vascular disease. Br Med J 1984; 288:592-594.
17. Das UN. Biological significance of arachidonic acid. Med Sci Res 1987; 24:1485-1490.
18. Moncada S. Nitric oxide in the vasculature: Physiology and pathophysiology. Ann NY Acad Sci 1997; 811:60-69.
19. Kumar KV, Das UN. Are free radicals involved in the pathophysiology of human essential hypertension? Free Rad Res Commun 1993; 19:59-66.
20. Rees D, Ben-Ishay D, Moncada S. Nitric oxide and the regulation of blood pressure in the hypertension-prone and hypertension-resistant Sabra rat. Hypertension 1996; 28:367-371.
21. Cachofeiro V, Sakakibara T, Nasiletti A. Kinins, nitric oxide and the hypertensive effect of captopril and ramipril in hypertension. Hypertension 1992; 19:138-145.
22. Kumar KV, Das UN. Effect of cis-unsaturated fatty acids, prostaglandins and free radicals on angiotensin converting enzyme activity in vitro. Proc Soc Exp Biol Med 1997; 214:374-379.
23. Suryaprabha P, Das UN, Koratkar R, Sagar PS, Ramesh G. Free radical generation, lipid peroxidation and essential fatty acids in uncontrolled essential hypertension. Prostaglandins Leukotrienes Essential Fatty Acids 1990; 41:27-33.
24. Das UN. Beneficial action(s) of eicosapentaenoic acid/docosahexaenoic acid and nitric oxide in systemic lupus erythematosus. Med Sci Res 1995; 23:723-726.
25. Haglund O, Mental JL, Salden T. Effects of fish oil on some parameters of fibrinolysis and lipoprotein (a) in healthy subjects. Am J Cardiol 1994; 74:189-192.
26. Bang HO, Dyerberg J, Nielsen AB. Plasma lipid and lipoprotein pattern in Greenlandic West coast Eskimos. Lancet 1971 ; i: 1143-1146.
27. Pauletto P, Puato M, Carold MG, Cagislia E, Munhambo AE, Cazzolato G et al. Blood pressure and atherogenic lipoprotein profiles of fish-diet and vegetarian villagers in Tanzania: the Lugalewa study. Lancet 1996; 348:784-788.
28. Nelson GJ, Schmidt PC, Bartolini G, Kelley DS, Phinney SD, Kyle D, et al. The effect of dietary arachidonic acid on plasma lipoprotein distributions, apoproteins, blood lipid levels, and tissue fatty acid composition in humans. Lipids 1997; 32:427-433.
29. Nelson GJ, Schmidt PC, Bartoloni G, Kelley DS, Kyle D. The effect of dietary arachidonic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids 1997; 32:42125.
30. Das UN. Essential fatty acids metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Prostaglandins Leukotrienes Essential Fatty Acids 1995; 52:387-391.
31. Padhani A, Dandona P. Diabetes and coronary heart disease in north London Asians. Lancet 1986; i:213-214.
32. Kagawa Y, Nishizawa M, Suzuki M, Miyatake T, Hamamoto T, Goto K et al. Eicosapentaenoic acids of serum lipids of Japanese Islanders with low incidence of cardiovascular diseases. J Nutr Sci Vitaminol 1982; 28:441-53.
33. Leaf A, Weber PC. Cardiovascular effects of n-3 fatty acids. New Engl J Med 1988; 318:549-557.
34. Juan H, Sametz W. Dihomo-gamma-linolenic acid increases the metabolism of eicosapentaenoic acid in perfused vascular tissue. Prostaglandins Leukotrienes Med 1985; 19:79-86.
35. Salonen JT, Alfthan G, Huttunen JK, Pikkarainen J, Puska P. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet 1982; ii: 175-179.
36. McVeigh GE, Brennan GM, Johnson GD, McDermott BJ, McGrath LT, Henry WR et al. Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1993; 36:33-38.
37. Mohan IK, Das UN. Effect of L-arginine-nitric oxide system on chemical induced diabetes mellitus. Free Rad Biol Med 1998; 25:757-765.
38. Reaven G. Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 1988; 37:1595-1607.
39. Das UN. Insulin resistance and hyperinsulinaemia: Are they secondary to an alteration in the metabolism of essential fatty acids? Med Sci Res 1994; 22:243-245.
40. Balarajan R, Bulusu L, Adelstein AM, Shukla V. Patterns of mortality among migrants to England and Wales from the Indian subcontinent. B r Med J 1984; 289:1185-1187.
41. Office of Population Censuses and Surveys. Mortality and geography. A review in the mid 1980s. The registrar-General's decennial supplement for England and Wales. Series DS 209, London: HMSO; 1990.
42. McKeigue PM, Marmot MG, Adelstein AM, Hunt SP, Shipley MJ, Butler SM, et al. Diet and risk factors for coronary heart disease in Asians in northwest London. Lancet 1985; ii: 1086-1090.
43. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337:382-386.
44. Yorek M, Leeney E, Dunlop J, Ginsberg B. Effect of fatty acid composition on insulin and IGF-I binding in retinoblastoma cells. Invest Ophthalmol Vis Sci 1989; 30:2087-2092.
45. Ginsberg BH, Chaterjee P, Yorek M. Increased membrane fluidity is associated with greatest sensitivity to insulin. Diabetes 1987; 36(suppl):51A (abstract).
46. Ginsberg BH, labour J, Spector AA Effect of alterations in membrane lipid unsaturation on the properties of the insulin receptor of Ehrlich ascites cells. Biochim Biophys Acta 1982; 690:157-164.
47. Grunfeld C, Baird KL, Kahn CR. Maintenance of 3T3-L1 cells in culture media containing saturated fatty acids decreases insulin binding and insulin action. Biochem Biophys Res Commun 1981; 103:219-226.
48. Hagre T-A. Effects of unsaturated fatty acids on cell membrane functions. ScandJ Clin Lab Invest 1988; 48:381-388.
49. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW. Influence of dietary fat composition on development of insulin resistance in rats: relationship to muscle triglycérides and w-3 fatty acids in muscle phospholipid. Diabetes 1991; 40:280-289.
50. Pelikanova T, Kohout M, Valek J, Base J, Kazdova L. Insulin secretion and insulin action related to the serum phospholipid fatty acid pattern in healthy men. Metabolism 1989; 38:188-192.
51. Das UN, Vijaykumar K, Ramesh G. Essential fatty acid metabolism in South Indians. Prostaglandins Leukotrienes Essential Fatty Acids 1994;50:253-255.
52. Huang YS, Das UN, Horrobin DF. Effect of dexamethasone on the distribution of essential fatty acids in plasma and liver phospholipids. IRCSMedSci 1986; 14:180-181.
53. Tilvis RS, Miettinen TA. Fatty acid composition of serum lipids, erythrocytes and platelets in insulin dependent diabetes. J Clin Endocrinol Metab 1985; 61:741-745.
54. Tilvis RS, Helve E, Miettinen TA. Improvement of diabetic control by continuous subcutaneous insulin infusion therapy changes fatty acid composition of serum lipids and erythrocytes in type 1 (insulin dependent) diabetes. Diabetologia 1986; 29:690-694.
55. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV. The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids. New EngI J Med 1993; 328:238-244.
56. Mohan IK, Das UN. Oxidant stress, anti-oxidant and nitric oxide in non-insulin dependent diabetes mellitus. Med Sci Res 1997; 25:55-57.